Every year, patients arrive at my clinic carrying a decision they did not expect: that they do not qualify for a liver transplant. Some were told the disease is too advanced. Others were told it is not yet severe enough to justify listing. A third group received what felt like an incomplete evaluation — one specialist’s view rather than a team’s — and are left unsure whether to accept it or push back.

All three groups have standing to seek a proper second opinion. Transplant listing is a decision with serious consequences on both sides: too early and the patient undergoes surgery they did not yet need; too late and a preventable death occurs. A structured, independent assessment at an accredited centre is the correct mechanism for resolving that uncertainty. Please consult a physician directly for guidance on your individual situation — the information here is educational, not a substitute for clinical assessment.

When Does Seeking a Second Opinion on Transplant Eligibility Make Sense?

There is no single threshold. The clearest clinical signal is a contraindication cited without adequate workup — suspected malignancy that was never properly staged, a cardiac finding not reviewed by a transplant cardiologist, or an infection that has since resolved. In these cases, the original decision rested on incomplete information, which a second evaluation can directly address.

A separate and equally valid signal: the first assessment was conducted by a single specialist rather than a multi-disciplinary transplant team. That alone justifies a repeat evaluation at a centre where hepatologist, surgeon, cardiologist, psychologist, and coordinator assess the patient in parallel. For patients whose condition has continued to evolve since a prior evaluation — and whose MELD score has risen in the intervening months — the original decision may simply no longer apply.

Our hepatology second-opinion service at Gleneagles is structured specifically for patients in this position, including those who have already received a transplant-ineligibility decision elsewhere.

What Criteria Determine Whether a Patient Qualifies for a Liver Transplant?

Eligibility rests on three overlapping questions. Is the liver disease severe enough to justify transplant? Is the patient physically and psychologically fit for major surgery and lifelong immunosuppression? And is there an absolute contraindication that would make the operation futile or unsafe?

MELD score — calculated from bilirubin, creatinine, INR, and serum sodium — answers the first question. It reflects short-term mortality risk from liver disease and determines allocation priority in India’s national deceased-donor system. Higher scores mean higher urgency; the score is recalculated as disease evolves. The benefit of transplant tracks MELD closely: in a US registry study of nearly 13,000 waiting-list patients, transplant increased one-year mortality at MELD below 15 and reduced it from MELD 18 upward (Merion et al., Am J Transplant 2005).

Fitness for surgery is assessed systematically — cardiac function (echocardiogram, coronary evaluation in higher-risk patients), pulmonary status, renal function, and nutritional reserve. Absolute contraindications such as active uncontrolled extrahepatic malignancy or irreversible severe cardiopulmonary disease must be positively confirmed, not merely suspected, before being applied to deny listing. That distinction is where a second opinion most often changes the outcome. For a fuller picture of the transplant evaluation process, see liver transplant in India — what patients need to know.

What Documents and Investigations Do You Need for a Second-Opinion Evaluation?

Practical preparation matters. For a transplant evaluation at Gleneagles, I ask patients to bring the following before the first appointment.

Medical records from the prior assessment — discharge summaries, outpatient clinic letters, any committee decision document or letter citing ineligibility. Recent laboratory results (within four to six weeks): LFTs, bilirubin, PT/INR, creatinine, serum sodium, full blood count, and viral serology — HBsAg, anti-HCV, HIV. Contrast CT or MRI of the abdomen: if hepatocellular carcinoma was part of the clinical picture, sequential imaging matters — tumour trajectory and response to locoregional therapy both affect eligibility under established transplant criteria. Cardiology records if a prior assessment was done. Current medication list, including any herbal preparations or supplements.

Some patients arrive with everything in order; others arrive with only a verbal account of what was communicated. Both situations are manageable, though a well-organised file makes the evaluation faster and the conclusions more reliable.

How Does the Transplant Eligibility Assessment Process Work in India?

India’s deceased-donor transplant system is administered through NOTTO (National Organ and Tissue Transplant Organisation) and regional zonal coordination committees. Listing at any NOTTO-accredited centre — Gleneagles Hospital Mumbai among them — integrates into the national pool. Priority is determined by MELD score, not by which centre registered the patient first.

The assessment at an accredited centre follows a consistent multi-disciplinary format. The hepatologist reviews disease severity, aetiology, and clinical trajectory. The transplant surgeon evaluates surgical feasibility — anatomy, portal vein status, prior abdominal surgery. A cardiologist provides independent cardiac clearance. A psychiatrist or clinical psychologist assesses understanding of the commitment involved and capacity for long-term adherence. A coordinator and social worker review the support network at home. Decisions are made by the transplant committee, not by a single physician. A genuine second opinion means repeating this full process — not obtaining one specialist’s endorsement of notes from another centre.

International and NRI patients considering India for evaluation will find the specific pathway described at liver transplant in India for international patients, and an overview of the full hepatology programme at our services page.

Can NRI Patients Get a Pre-Assessment Remotely Before Travelling to India?

A meaningful preliminary assessment is possible remotely. The formal multi-disciplinary evaluation — investigations, MDT review, committee decision — requires physical presence, but a great deal of useful work can be done before the patient boards a flight.

For NRI patients, the practical sequence begins with sharing existing records and imaging through the hospital’s international patient team ahead of a video consultation. The hepatologist can review the material, estimate the likelihood of listing, identify any obvious absolute contraindication that would make immediate travel unnecessary, and advise on investigations to complete locally before arriving. This triage step is genuinely useful — arriving prepared is not just more convenient; it means the clinical evaluation itself can proceed without delay and the team has what they need to reach a clear conclusion within the visit.

Patients from the Gulf region, the UK, East Africa, and North America have used this preliminary step effectively before travelling to Gleneagles for their full transplant evaluation.